4//SEC Filing
CAVAZZA CLAUDIO 4
Accession 0001140361-10-026305
CIK 0000812796other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:59 PM ET
Size
8.8 KB
Accession
0001140361-10-026305
Insider Transaction Report
Form 4
SOLIGENIX, INC.SNGX
CAVAZZA CLAUDIO
10% Owner
Transactions
- Purchase
Common Stock
2010-06-18$0.20/sh+8,608,580$1,764,759→ 54,227,816 total(indirect: Indirect) - Other
Common Stock Warrant (warrant to buy)
2010-06-18+1→ 1 total(indirect: Indirect)Exercise: $0.28From: 2010-06-18Exp: 2015-06-18→ Common Stock (5,165,148 underlying)
Footnotes (3)
- [F1]Shares directly owned by Sigma-Tau Pharmaceuticals, Inc. ("Pharmaceuticals"). Pharmaceuticals is a direct wholly-owned subsidiary of Sigma-Tau America S.A. ("America"). America is a direct wholly-owned subsidiary of Sigma-Tau International S.A. ("International"). International is a direct wholly-owned subsidiary of Sigma-Tau Finanziaria S.p.A. ("Sigma Tau"). Claudio Cavazza directly and indirectly owns 57% of Sigma Tau.
- [F2]This warrant was issued by the Issuer to Pharmaceuticals in consideration of Pharmaceuticals' purchase of 8,608,580 shares of common stock on June 18, 2010.
- [F3]The expiration date of the warrant may be accelerated at the Issuer's option if the Issuer's common stock meets certain price thresholds and the common shares underlying the warrant are registered for resale pursuant to an effective registration statement or are freely transferable without volume restrictions pursuant to Rule 144 under the Securities Act of 1933, as amended.
Documents
Issuer
SOLIGENIX, INC.
CIK 0000812796
Entity typeother
Related Parties
1- filerCIK 0001164803
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:59 PM ET
- Size
- 8.8 KB